INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc.

Open the article to view the coverage from Kilgore News Herald

5,638 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Bridgewater Advisors Inc.

Bridgewater Advisors Inc. purchased a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 5,638 shares of the biopharmaceutical company’s stock, valued at approximately $588,000. Other institutional investors and hedge […]

Triasima Portfolio Management inc. Purchases New Position in Gilead Sciences, Inc. (NASDAQ:GILD)

Triasima Portfolio Management inc. purchased a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 3,695 shares of the biopharmaceutical company’s stock, valued at approximately $414,000. Other large investors have also […]